- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Take Our Survey for a $200 Discount on This Year's CBI Product Launch Summit
CBI's 4th Bio/Pharmaceutical Product Launch Summit runs in Cambridge, MA, on September 25-26. This year's speakers-including Jasmine Daniel, Direcor, US Patient Services at Shire and Diana Dai, Executive Director, US Pipeline and Launch Management at Sandoz-will shine a light on identifying keys to early commercialization and ensuring post-launch success.
You can receive a $200 discount off this event's registration rate by completing this very short survey:
https://www.surveymonkey.com/r/3TW2KF6
(Discount expires August 31, 2018).
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
